Gut bacteria diversity, digestive health, probiotics, prebiotics, and the gut-brain axis
256 articles
Study reveals how gut bacteriophages change with age and may contribute to fatty liver disease while harboring dangerous antibiotic resistance genes.
Researchers found 651 viral proteins that disable bacterial immune systems in the human gut, revealing new therapeutic targets.
Phase 1 trial finds vaginal Lactobacillus therapy helps restore healthy microbiome after antibiotic treatment for bacterial vaginosis.
New research reveals how a specific gut pathogen destroys enteric neurons in IBD patients and identifies a potential bacteriophage treatment.
New research reveals how specific gut bacteria produce compounds that interfere with cancer treatment effectiveness.
New research reveals how certain immune cells create alternative blood vessels that fuel pancreatic cancer growth and spread.
New fusion model accurately predicts survival outcomes for liver cancer patients receiving TACE therapy using CT scans and biomarkers.
Study reveals how IL-6 inflammation protein fuels liver cancer growth and identifies potential therapeutic vulnerability.
New research reveals how tumors directly absorb inflammatory fats from food, offering potential dietary intervention targets.
Middle-aged woman's submucosal rectal lesion demonstrates critical need for precise endoscopic evaluation methods.
New research calls for refined approaches to identify and monitor liver disease risk in non-obese patients with fatty liver.
New research reveals how disrupted gut microbiome and bile acid metabolism increase cancer risk in PSC patients.
